Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension

C‐H. Chen Division of Allergy, Immunology and Rheumatology; National Yang‐Ming Medical University, Taiwan

H‐A. Chen Division of Allergy, Immunology and Rheumatology; National Yang‐Ming Medical University, Taiwan

K‐Y. Yang Chest Department; National Yang‐Ming Medical University, Taiwan

W‐C. Yu Division of Cardiology, Department of Medicine, Veterans General Hospital, Taipei; National Yang‐Ming Medical University, Taiwan

H‐T. Liao Division of Allergy, Immunology and Rheumatology; National Yang‐Ming Medical University, Taiwan

D‐F. Huang Division of Allergy, Immunology and Rheumatology; National Yang‐Ming Medical University, TaiwanCorrespondence[email protected]

References

Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H. M., Alexander E. L., Carsons S. E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 2002; 61: 554–8
PubMed Web of Science ®Google Scholar
Humbert M., Sitbon O., Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425–36
PubMed Web of Science ®Google Scholar
Channick R. N., Sitbon O., Barst R. J., Manes A., Rubin L. J. Endothelin receptor antagonists in pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43(Suppl 12): S62–7
Google Scholar
Hedgpeth M. T., Boulware D. W. Pulmonary hypertension in primary Sjögren's syndrome. Ann Rheum Dis 1988; 47: 251–3
PubMed Web of Science ®Google Scholar
Sato T., Matsubara O., Tanaka Y., Kasuga T. Association of Sjögren's syndrome with pulmonary hypertension: report of two cases and review of the literature. Hum Pathol 1993; 24: 199–205
PubMed Web of Science ®Google Scholar
Aslaksen H. K., Nossent H. C. Fatal pulmonary hypertension in primary Söjgren's syndrome. Clin Exp Rheumatol 2004; 22: 507
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date